Guided Therapeutics (GTHP) Research & Development (2010 - 2025)
Guided Therapeutics recorded quarterly Research & Development of $127000.0 in Q4 2025, down 6.62% quarter-over-quarter from $136000.0 in Q3 2025, and down 9.29% year-over-year from $140000.0 in Q4 2024.
Guided Therapeutics' Research & Development history runs 16 years deep, the most recent figure standing at $127000.0 for Q4 2025.
- In Q4 2025, Research & Development fell 9.29% year-over-year to $127000.0; the TTM figure through Dec 2025 stood at $470000.0 (down 10.82% YoY), while the FY2025 annual figure was $469000.0, down 10.84% from the prior year.
- Research & Development came in at $127000.0 for Q4 2025 at Guided Therapeutics, down from $136000.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $222000.0 in Q2 2024 to a low of $7000.0 in Q1 2023.
- A 5-year average of $68550.0 and a median of $60000.0 in 2023 frame the typical range for Research & Development.
- On a YoY basis, Research & Development climbed as much as 762.5% in 2023 and fell as far as 66.67% in 2023.
- Guided Therapeutics' Research & Development stood at $17000.0 in 2021, then soared by 129.41% to $39000.0 in 2022, then soared by 120.51% to $86000.0 in 2023, then soared by 62.79% to $140000.0 in 2024, then dropped by 9.29% to $127000.0 in 2025.
- According to Business Quant data, Research & Development over the past three periods registered $127000.0, $136000.0, and $133000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | 127,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 127,000.00 |
| Sep 30, 2025 | 136,000.00 |
| Jun 30, 2025 | 133,000.00 |
| Mar 31, 2025 | 74,000.00 |
| Dec 31, 2024 | 140,000.00 |
| Sep 30, 2024 | 111,000.00 |
| Jun 30, 2024 | 222,000.00 |
| Mar 31, 2024 | 54,000.00 |
| Dec 31, 2023 | 86,000.00 |
| Sep 30, 2023 | 69,000.00 |
| Jun 30, 2023 | 66,000.00 |
| Mar 31, 2023 | 7,000.00 |
| Dec 31, 2022 | 39,000.00 |
| Sep 30, 2022 | 8,000.00 |
| Jun 30, 2022 | 9,000.00 |
| Mar 31, 2022 | 21,000.00 |
| Dec 31, 2021 | 17,000.00 |
| Sep 30, 2021 | 16,000.00 |
| Jun 30, 2021 | 20,000.00 |
| Mar 31, 2021 | 16,000.00 |
| Dec 31, 2020 | 22,000.00 |
| Sep 30, 2020 | 41,000.00 |
| Jun 30, 2020 | 55,000.00 |
| Mar 31, 2020 | 24,000.00 |
| Dec 31, 2019 | 9,000.00 |
| Sep 30, 2019 | 23,000.00 |
| Jun 30, 2019 | 43,000.00 |
| Mar 31, 2019 | 47,000.00 |
| Dec 31, 2018 | 69,000.00 |
| Sep 30, 2018 | 43,000.00 |
| Jun 30, 2018 | 62,000.00 |
| Mar 31, 2018 | 69,000.00 |
| Dec 31, 2017 | 83,000.00 |
| Sep 30, 2017 | 69,000.00 |
| Jun 30, 2017 | 89,000.00 |
| Mar 31, 2017 | 91,000.00 |
| Dec 31, 2016 | 208,000.00 |
| Sep 30, 2016 | 87,000.00 |
| Jun 30, 2016 | 148,000.00 |
| Mar 31, 2016 | 290,000.00 |
| Dec 31, 2015 | 387,000.00 |
| Sep 30, 2015 | 413,000.00 |
| Jun 30, 2015 | 305,000.00 |
| Mar 31, 2015 | 373,000.00 |
| Dec 31, 2014 | 666,000.00 |
| Sep 30, 2014 | 892,000.00 |
| Jun 30, 2014 | 624,000.00 |
| Mar 31, 2014 | 607,000.00 |
| Dec 31, 2013 | 499,000.00 |
| Sep 30, 2013 | 596,000.00 |
| Jun 30, 2013 | 834,000.00 |
| Mar 31, 2013 | 813,000.00 |
| Dec 31, 2012 | 830,000.00 |
| Sep 30, 2012 | 787,000.00 |
| Jun 30, 2012 | 898,000.00 |
| Mar 31, 2012 | 714,000.00 |
| Dec 31, 2011 | 755,000.00 |
| Sep 30, 2011 | 709,000.00 |
| Jun 30, 2011 | 619,000.00 |
| Mar 31, 2011 | 696,000.00 |
| Jun 30, 2010 | 490,000.00 |